<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35445729</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1791-244X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>49</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>International journal of molecular medicine</Title>
          <ISOAbbreviation>Int J Mol Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Curcumin and Wnt/β‑catenin signaling in exudative age‑related macular degeneration (Review).</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">79</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3892/ijmm.2022.5135</ELocationID>
        <Abstract>
          <AbstractText>Curcumin is a natural product widely used due to its pharmacological effects. Nevertheless, only a limited number of studies concerning the effects of curcumin on exudative age‑related macular degeneration (AMD) is currently available. Since ophthalmic diseases, including exudative AMD, have a marked impact on public health, the prevention and therapy of ophthalmic disorders remain of increasing concern. Exudative AMD is characterized by choroidal neovascularization (CNV) invading the subretinal space, ultimately enhancing exudation and hemorrhaging. The exudative AMD subtype corresponds to 10 to 15% of cases of macular degeneration; however, the occurrence of this subtype has been reported as the major cause of vision loss and blindness, with the occurrence of CNV being responsible for 80% of the cases with vision loss. In CNV increased expression of VEGF has been observed, stimulated by the overactivation of Wnt/β‑catenin signaling pathway. The stimulation of the Wnt/β‑catenin signaling pathway is responsible for the activation of several cellular mechanisms, simultaneously enhancing inflammation, oxidative stress and angiogenesis in numerous diseases, including ophthalmic disorders. Some studies have previously demonstrated the possible advantage of the use of curcumin for the inhibition of Wnt/β‑catenin signaling. In the present review article, the different mechanisms of curcumin are described concerning its effects on oxidative stress, inflammation and angiogenesis in exudative AMD, by interacting with Wnt/β‑catenin signaling.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Vallée</LastName>
            <ForeName>Alexandre</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology‑Data‑Biostatistics, Delegation of Clinical Research and Innovation (DRCI), Foch Hospital, 92150 Suresnes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Mol Med</MedlineTA>
        <NlmUniqueID>9810955</NlmUniqueID>
        <ISSNLinking>1107-3756</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051176">beta Catenin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>IT942ZTH98</RegistryNumber>
          <NameOfSubstance UI="D003474">Curcumin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D020256" MajorTopicYN="Y">Choroidal Neovascularization</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003474" MajorTopicYN="Y">Curcumin</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005128" MajorTopicYN="Y">Eye Diseases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008268" MajorTopicYN="Y">Macular Degeneration</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060449" MajorTopicYN="N">Wnt Signaling Pathway</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051176" MajorTopicYN="N">beta Catenin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">VEGF</Keyword>
        <Keyword MajorTopicYN="N">Wnt</Keyword>
        <Keyword MajorTopicYN="N">age‑related macular degeneration</Keyword>
        <Keyword MajorTopicYN="N">angiogenesis</Keyword>
        <Keyword MajorTopicYN="N">curcumin</Keyword>
        <Keyword MajorTopicYN="N">inflammation</Keyword>
        <Keyword MajorTopicYN="N">oxidative stress</Keyword>
      </KeywordList>
      <CoiStatement>The author declares that he has no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>21</Day>
          <Hour>8</Hour>
          <Minute>46</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35445729</ArticleId>
        <ArticleId IdType="pmc">PMC9083851</ArticleId>
        <ArticleId IdType="doi">10.3892/ijmm.2022.5135</ArticleId>
        <ArticleId IdType="pii">79</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bird AC. Therapeutic targets in age-related macular disease. J Clin Invest. 2010;120:3033–3041. doi: 10.1172/JCI42437.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI42437</ArticleId>
            <ArticleId IdType="pmc">PMC2929720</ArticleId>
            <ArticleId IdType="pubmed">20811159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radomska-Leśniewska DM, Skopiński P, Bałan BJ, Białoszewska A, Jóźwiak J, Rokicki D, Skopińska-Różewska E, Borecka A, Hevelke A. Angiomodulatory properties of Rhodiola spp. and other natural antioxidants. Cent Eur J Immunol. 2015;40:249–262. doi: 10.5114/ceji.2015.52839.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5114/ceji.2015.52839</ArticleId>
            <ArticleId IdType="pmc">PMC4637400</ArticleId>
            <ArticleId IdType="pubmed">26557041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radomska-Leśniewska DM, Bałan BJ, Skopiński P. Angiogenesis modulation by exogenous antioxidants. Cent Eur J Immunol. 2017;42:370–376. doi: 10.5114/ceji.2017.72804.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5114/ceji.2017.72804</ArticleId>
            <ArticleId IdType="pmc">PMC5820975</ArticleId>
            <ArticleId IdType="pubmed">29472815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vallée A, Lecarpentier Y, Guillevin R, Vallée JN. PPARγ agonists: Potential treatments for exudative age-related macular degeneration. Life Sci. 2017;188:123–130. doi: 10.1016/j.lfs.2017.09.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lfs.2017.09.008</ArticleId>
            <ArticleId IdType="pubmed">28887057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coffe V, Carbajal RC, Salceda R. Glucose metabolism in rat retinal pigment epithelium. Neurochem Res. 2006;31:103–108. doi: 10.1007/s11064-005-9236-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11064-005-9236-7</ArticleId>
            <ArticleId IdType="pubmed">16475003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaur C, Foulds WS, Ling EA. Hypoxia-ischemia and retinal ganglion cell damage. Clin Ophthalmol. 2008;2:879–889. doi: 10.2147/OPTH.S3361.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/OPTH.S3361</ArticleId>
            <ArticleId IdType="pmc">PMC2699791</ArticleId>
            <ArticleId IdType="pubmed">19668442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferris FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984;102:1640, 1642. doi: 10.1001/archopht.1984.01040031330019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archopht.1984.01040031330019</ArticleId>
            <ArticleId IdType="pubmed">6208888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barchitta M, Maugeri A. Association between vascular endothelial growth factor polymorphisms and age-related macular degeneration: An updated meta-analysis. Dis Markers. 2016;2016:8486406. doi: 10.1155/2016/8486406.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2016/8486406</ArticleId>
            <ArticleId IdType="pmc">PMC5141552</ArticleId>
            <ArticleId IdType="pubmed">27999450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin F, Boveris A, Cadenas E. Mitochondrial energy metabolism and redox signaling in brain aging and neurodegeneration. Antioxid Redox Signal. 2014;20:353–371. doi: 10.1089/ars.2012.4774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2012.4774</ArticleId>
            <ArticleId IdType="pmc">PMC3887431</ArticleId>
            <ArticleId IdType="pubmed">22793257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vallée A, Lecarpentier Y, Guillevin R, Vallée JN. opposite interplay between the canonical WNT/β-catenin pathway and PPAR Gamma: A potential therapeutic target in gliomas. Neurosci Bull. 2018;34:573–588. doi: 10.1007/s12264-018-0219-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12264-018-0219-5</ArticleId>
            <ArticleId IdType="pmc">PMC5960455</ArticleId>
            <ArticleId IdType="pubmed">29582250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vallée A, Lecarpentier Y, Vallée JN. Curcumin: A therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway. J Exp Clin Cancer Res. 2019;38:323. doi: 10.1186/s13046-019-1320-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13046-019-1320-y</ArticleId>
            <ArticleId IdType="pmc">PMC6647277</ArticleId>
            <ArticleId IdType="pubmed">31331376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yeung AWK, Horbańczuk M, Tzvetkov NT, Mocan A, Carradori S, Maggi F, Marchewka J, Sut S, Dall'Acqua S, Gan RY, et al.  Curcumin: Total-scale analysis of the scientific literature. Molecules. 2019;24:1393. doi: 10.3390/molecules24071393.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules24071393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kao YW, Hsu SK, Chen JY, Lin IL, Chen KJ, Lee PY, Ng HS, Chiu CC, Cheng KC. Curcumin metabolite tetrahydrocurcumin in the treatment of eye diseases. Int J Mol Sci. 2020;22:212. doi: 10.3390/ijms22010212.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms22010212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhutto I, Lutty G. Understanding age-related macular degeneration (AMD): Relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. Mol Aspects Med. 2012;33:295–317. doi: 10.1016/j.mam.2012.04.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mam.2012.04.005</ArticleId>
            <ArticleId IdType="pmc">PMC3392421</ArticleId>
            <ArticleId IdType="pubmed">22542780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McLeod DS, Grebe R, Bhutto I, Merges C, Baba T, Lutty GA. Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2009;50:4982–4991. doi: 10.1167/iovs.09-3639.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1167/iovs.09-3639</ArticleId>
            <ArticleId IdType="pmc">PMC4829357</ArticleId>
            <ArticleId IdType="pubmed">19357355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takata S, Masuda T, Nakamura S, Kuchimaru T, Tsuruma K, Shimazawa M, Nagasawa H, Kizaka-Kondoh S, Hara H. The effect of triamcinolone acetonide on laser-induced choroidal neovascularization in mice using a hypoxia visualization bio-imaging probe. Sci Rep. 2015;5:9898. doi: 10.1038/srep09898.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep09898</ArticleId>
            <ArticleId IdType="pmc">PMC4415651</ArticleId>
            <ArticleId IdType="pubmed">25927172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakurai E, Anand A, Ambati BK, van Rooijen N, Ambati J. Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2003;44:3578–3585. doi: 10.1167/iovs.03-0097.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1167/iovs.03-0097</ArticleId>
            <ArticleId IdType="pubmed">12882810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Indaram M, Ma W, Zhao L, Fariss RN, Rodriguez IR, Wong WT. 7-Ketocholesterol increases retinal microglial migration, activation, and angiogenicity: A potential pathogenic mechanism underlying age-related macular degeneration. Sci Rep. 2015;5:9144. doi: 10.1038/srep09144.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep09144</ArticleId>
            <ArticleId IdType="pmc">PMC4360733</ArticleId>
            <ArticleId IdType="pubmed">25775051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terasaki H, Kase S, Shirasawa M, Otsuka H, Hisatomi T, Sonoda S, Ishida S, Ishibashi T, Sakamoto T. TNF-α decreases VEGF secretion in highly polarized RPE cells but increases it in non-polarized RPE cells related to crosstalk between JNK and NF-κB pathways. PLoS One. 2013;8:e69994. doi: 10.1371/journal.pone.0069994.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0069994</ArticleId>
            <ArticleId IdType="pmc">PMC3726732</ArticleId>
            <ArticleId IdType="pubmed">23922887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu Y, Chen Y, Lin M, Lee K, Mott RA, Ma J. Pathogenic role of the Wnt signaling pathway activation in laser-induced choroidal neovascularization. Invest Ophthalmol Vis Sci. 2013;54:141–154. doi: 10.1167/iovs.12-10281.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1167/iovs.12-10281</ArticleId>
            <ArticleId IdType="pmc">PMC3544418</ArticleId>
            <ArticleId IdType="pubmed">23211829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tuo J, Wang Y, Cheng R, Li Y, Chen M, Qiu F, Qian H, Shen D, Penalva R, Xu H, et al.  Wnt signaling in age-related macular degeneration: Human macular tissue and mouse model. J Transl Med. 2015;13:330. doi: 10.1186/s12967-015-0683-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12967-015-0683-x</ArticleId>
            <ArticleId IdType="pmc">PMC4609061</ArticleId>
            <ArticleId IdType="pubmed">26476672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nussenblatt RB, Ferris F. Age-related macular degeneration and the immune response: Implications for therapy. Am J Ophthalmol. 2007;144:618–626. doi: 10.1016/j.ajo.2007.06.025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajo.2007.06.025</ArticleId>
            <ArticleId IdType="pmc">PMC2744410</ArticleId>
            <ArticleId IdType="pubmed">17698021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radeke MJ, Radeke CM, Shih YH, Hu J, Bok D, Johnson LV, Coffey PJ. Restoration of mesenchymal retinal pigmented epithelial cells by TGFβ pathway inhibitors: Implications for age-related macular degeneration. Genome Med. 2015;7:58. doi: 10.1186/s13073-015-0183-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13073-015-0183-x</ArticleId>
            <ArticleId IdType="pmc">PMC4491894</ArticleId>
            <ArticleId IdType="pubmed">26150894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin CH, Li CH, Liao PL, Tse LS, Huang WK, Cheng HW, Cheng YW. Silibinin inhibits VEGF secretion and age-related macular degeneration in a hypoxia-dependent manner through the PI-3 kinase/Akt/mTOR pathway. Br J Pharmacol. 2013;168:920–931. doi: 10.1111/j.1476-5381.2012.02227.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1476-5381.2012.02227.x</ArticleId>
            <ArticleId IdType="pmc">PMC3631380</ArticleId>
            <ArticleId IdType="pubmed">23004355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ambati J. Age-related macular degeneration and the other double helix. The Cogan lecture. Invest Ophthalmol Vis Sci. 2011;52:2165–2169. doi: 10.1167/iovs.11-7328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1167/iovs.11-7328</ArticleId>
            <ArticleId IdType="pmc">PMC3080169</ArticleId>
            <ArticleId IdType="pubmed">21471430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blasiak J, Petrovski G, Veréb Z, Facskó A, Kaarniranta K. Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration. Biomed Res Int. 2014;2014:768026. doi: 10.1155/2014/768026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/768026</ArticleId>
            <ArticleId IdType="pmc">PMC3950832</ArticleId>
            <ArticleId IdType="pubmed">24707498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jaffe GJ, Eliott D, Wells JA, Prenner JL, Papp A, Patel S. A Phase 1 study of Intravitreous E10030 in combination with ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2016;123:78–85. doi: 10.1016/j.ophtha.2015.09.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ophtha.2015.09.004</ArticleId>
            <ArticleId IdType="pubmed">26499921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kwak N, Okamoto N, Wood JM, Campochiaro PA. VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2000;41:3158–3164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10967078</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S, ANCHOR Study Group  Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432–1444. doi: 10.1056/NEJMoa062655.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa062655</ArticleId>
            <ArticleId IdType="pubmed">17021319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group  Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–1431. doi: 10.1056/NEJMoa054481.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa054481</ArticleId>
            <ArticleId IdType="pubmed">17021318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang X, Gaspard JP, Chung DC. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res. 2001;61:6050–6054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11507052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katoh Y, Katoh M. Comparative integromics on VEGF family members. Int J Oncol. 2006;28:1585–1589.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16685460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou T, Hu Y, Chen Y, Zhou KK, Zhang B, Gao G, Ma J. The pathogenic role of the canonical Wnt pathway in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010;51:4371–4379. doi: 10.1167/iovs.09-4278.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1167/iovs.09-4278</ArticleId>
            <ArticleId IdType="pmc">PMC2941176</ArticleId>
            <ArticleId IdType="pubmed">19875668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma B, Hottiger MO. Crosstalk between Wnt/β-catenin and NF-κB signaling pathway during inflammation. Front Immunol. 2016;7:378. doi: 10.3389/fimmu.2016.00378.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2016.00378</ArticleId>
            <ArticleId IdType="pmc">PMC5031610</ArticleId>
            <ArticleId IdType="pubmed">27713747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H, Hartnett ME. Regulation of signaling events involved in the pathophysiology of neovascular AMD. Mol Vis. 2016;22:189–202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4789180</ArticleId>
            <ArticleId IdType="pubmed">27013848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al-Harthi L. Wnt/β-catenin and its diverse physiological cell signaling pathways in neurodegenerative and neuropsychiatric disorders. J Neuroimmune Pharmacol. 2012;7:725–730. doi: 10.1007/s11481-012-9412-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11481-012-9412-x</ArticleId>
            <ArticleId IdType="pmc">PMC3690588</ArticleId>
            <ArticleId IdType="pubmed">23114888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004;20:781–810. doi: 10.1146/annurev.cellbio.20.010403.113126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.cellbio.20.010403.113126</ArticleId>
            <ArticleId IdType="pubmed">15473860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8:387–398. doi: 10.1038/nrc2389.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrc2389</ArticleId>
            <ArticleId IdType="pubmed">18432252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fuhrmann S. Wnt signaling in eye organogenesis. Organogenesis. 2008;4:60–67. doi: 10.4161/org.4.2.5850.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/org.4.2.5850</ArticleId>
            <ArticleId IdType="pmc">PMC2613311</ArticleId>
            <ArticleId IdType="pubmed">19122781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujimura N. WNT/β-catenin signaling in vertebrate eye development. Front Cell Dev Biol. 2016;4:138. doi: 10.3389/fcell.2016.00138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcell.2016.00138</ArticleId>
            <ArticleId IdType="pmc">PMC5127792</ArticleId>
            <ArticleId IdType="pubmed">27965955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Machon O, Kreslova J, Ruzickova J, Vacik T, Klimova L, Fujimura N, Lachova J, Kozmik Z. Lens morphogenesis is dependent on Pax6-mediated inhibition of the canonical Wnt/beta-catenin signaling in the lens surface ectoderm. Genesis. 2010;48:86–95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20027618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carpenter AC, Smith AN, Wagner H, Cohen-Tayar Y, Rao S, Wallace V, Ashery-Padan R, Lang RA. Wnt ligands from the embryonic surface ectoderm regulate 'bimetallic strip' optic cup morphogenesis in mouse. Development. 2015;142:972–982. doi: 10.1242/dev.120022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.120022</ArticleId>
            <ArticleId IdType="pmc">PMC4352985</ArticleId>
            <ArticleId IdType="pubmed">25715397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hägglund AC, Berghard A, Carlsson L. Canonical Wnt/β-catenin signalling is essential for optic cup formation. PLoS One. 2013;8:e81158. doi: 10.1371/journal.pone.0081158.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0081158</ArticleId>
            <ArticleId IdType="pmc">PMC3852023</ArticleId>
            <ArticleId IdType="pubmed">24324671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birdsey GM, Shah AV, Dufton N, Reynolds LE, Osuna Almagro L, Yang Y, Aspalter IM, Khan ST, Mason JC, Dejana E, et al.  The endothelial transcription factor ERG promotes vascular stability and growth through Wnt/β-catenin signaling. Dev Cell. 2015;32:82–96. doi: 10.1016/j.devcel.2014.11.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2014.11.016</ArticleId>
            <ArticleId IdType="pmc">PMC4292982</ArticleId>
            <ArticleId IdType="pubmed">25584796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ye X, Wang Y, Cahill H, Yu M, Badea TC, Smallwood PM, Peachey NS, Nathans J. Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell. 2009;139:285–298. doi: 10.1016/j.cell.2009.07.047.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2009.07.047</ArticleId>
            <ArticleId IdType="pmc">PMC2779707</ArticleId>
            <ArticleId IdType="pubmed">19837032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou Y, Wang Y, Tischfield M, Williams J, Smallwood PM, Rattner A, Taketo MM, Nathans J. Canonical WNT signaling components in vascular development and barrier formation. J Clin Invest. 2014;124:3825–3846. doi: 10.1172/JCI76431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI76431</ArticleId>
            <ArticleId IdType="pmc">PMC4151216</ArticleId>
            <ArticleId IdType="pubmed">25083995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang W, Li Q, Amiry-Moghaddam M, Hokama M, Sardi SH, Nagao M, Warman ML, Olsen BR. Critical endothelial regulation by LRP5 during retinal vascular development. PLoS One. 2016;11:e0152833. doi: 10.1371/journal.pone.0152833.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0152833</ArticleId>
            <ArticleId IdType="pmc">PMC4816525</ArticleId>
            <ArticleId IdType="pubmed">27031698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA. 1999;96:5522–5527. doi: 10.1073/pnas.96.10.5522.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.96.10.5522</ArticleId>
            <ArticleId IdType="pmc">PMC21892</ArticleId>
            <ArticleId IdType="pubmed">10318916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nusse R. Wnt signaling. Cold Spring Harb Perspect Biol. 2012;4:a011163. doi: 10.1101/cshperspect.a011163.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/cshperspect.a011163</ArticleId>
            <ArticleId IdType="pmc">PMC3331700</ArticleId>
            <ArticleId IdType="pubmed">22550232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clevers H, Nusse R. Wnt/β-catenin signaling and disease. Cell. 2012;149:1192–1205. doi: 10.1016/j.cell.2012.05.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2012.05.012</ArticleId>
            <ArticleId IdType="pubmed">22682243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sprowl-Tanio S, Habowski AN, Pate KT, McQuade MM, Wang K, Edwards RA, Grun F, Lyou Y, Waterman ML. Lactate/pyruvate transporter MCT-1 is a direct Wnt target that confers sensitivity to 3-bromopyruvate in colon cancer. Cancer Metab. 2016;4:20. doi: 10.1186/s40170-016-0159-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s40170-016-0159-3</ArticleId>
            <ArticleId IdType="pmc">PMC5046889</ArticleId>
            <ArticleId IdType="pubmed">27729975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pate KT, Stringari C, Sprowl-Tanio S, Wang K, TeSlaa T, Hoverter NP, McQuade MM, Garner C, Digman MA, Teitell MA, et al.  Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. EMBO J. 2014;33:1454–1473. doi: 10.15252/embj.201488598.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15252/embj.201488598</ArticleId>
            <ArticleId IdType="pmc">PMC4194089</ArticleId>
            <ArticleId IdType="pubmed">24825347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao C, Xiao G, Hu J. Regulation of Wnt/β-catenin signaling by posttranslational modifications. Cell Biosci. 2014;4:13. doi: 10.1186/2045-3701-4-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/2045-3701-4-13</ArticleId>
            <ArticleId IdType="pmc">PMC3977945</ArticleId>
            <ArticleId IdType="pubmed">24594309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cruciat CM, Niehrs C. Secreted and transmembrane Wnt inhibitors and activators. Cold Spring Harb Perspect Biol. 2013;5:a015081. doi: 10.1101/cshperspect.a015081.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/cshperspect.a015081</ArticleId>
            <ArticleId IdType="pmc">PMC3578365</ArticleId>
            <ArticleId IdType="pubmed">23085770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 1997;16:3797–3804. doi: 10.1093/emboj/16.13.3797.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/emboj/16.13.3797</ArticleId>
            <ArticleId IdType="pmc">PMC1170003</ArticleId>
            <ArticleId IdType="pubmed">9233789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu D, Pan W. GSK3: A multifaceted kinase in Wnt signaling. Trends Biochem Sci. 2010;35:161–168. doi: 10.1016/j.tibs.2009.10.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tibs.2009.10.002</ArticleId>
            <ArticleId IdType="pmc">PMC2834833</ArticleId>
            <ArticleId IdType="pubmed">19884009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hur EM, Zhou FQ. GSK3 signalling in neural development. Nat Rev Neurosci. 2010;11:539–551. doi: 10.1038/nrn2870.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrn2870</ArticleId>
            <ArticleId IdType="pmc">PMC3533361</ArticleId>
            <ArticleId IdType="pubmed">20648061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ambacher KK, Pitzul KB, Karajgikar M, Hamilton A, Ferguson SS, Cregan SP. The JNK- and AKT/GSK3β-signaling pathways converge to regulate puma induction and neuronal apoptosis induced by trophic factor deprivation. PLoS One. 2012;7:e46885. doi: 10.1371/journal.pone.0046885.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0046885</ArticleId>
            <ArticleId IdType="pmc">PMC3463558</ArticleId>
            <ArticleId IdType="pubmed">23056511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yokosako K, Mimura T, Funatsu H, Noma H, Goto M, Kamei Y, Kondo A, Matsubara M. Glycolysis in patients with age-related macular degeneration. Open Ophthalmol J. 2014;8:39–47. doi: 10.2174/1874364101408010039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1874364101408010039</ArticleId>
            <ArticleId IdType="pmc">PMC4150380</ArticleId>
            <ArticleId IdType="pubmed">25191529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grossniklaus HE, Kang SJ, Berglin L. Animal models of choroidal and retinal neovascularization. Prog Retin Eye Res. 2010;29:500–519. doi: 10.1016/j.preteyeres.2010.05.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.preteyeres.2010.05.003</ArticleId>
            <ArticleId IdType="pmc">PMC2962694</ArticleId>
            <ArticleId IdType="pubmed">20488255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, Liu CH, Huang S, Chen J. Wnt Signaling in vascular eye diseases. Prog Retin Eye Res. 2019;70:110–133. doi: 10.1016/j.preteyeres.2018.11.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.preteyeres.2018.11.008</ArticleId>
            <ArticleId IdType="pmc">PMC6545170</ArticleId>
            <ArticleId IdType="pubmed">30513356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, Cheng R, Lee K, Tyagi P, Ding L, Kompella UB, Chen J, Xu X, Ma JX. Nanoparticle-mediated expression of a wnt pathway inhibitor ameliorates ocular neovascularization. Arterioscler Thromb Vasc Biol. 2015;35:855–864. doi: 10.1161/ATVBAHA.114.304627.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/ATVBAHA.114.304627</ArticleId>
            <ArticleId IdType="pmc">PMC4376607</ArticleId>
            <ArticleId IdType="pubmed">25657312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Y, Hu Y, Lu K, Flannery JG, Ma JX. Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization. J Biol Chem. 2007;282:34420–34428. doi: 10.1074/jbc.M611289200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M611289200</ArticleId>
            <ArticleId IdType="pubmed">17890782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin JB, Sene A, Wiley LA, Santeford A, Nudleman E, Nakamura R, Lin JB, Moolani HV, Apte RS. WNT7A/B promote choroidal neovascularization. Exp Eye Res. 2018;174:107–112. doi: 10.1016/j.exer.2018.05.033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.exer.2018.05.033</ArticleId>
            <ArticleId IdType="pmc">PMC6110966</ArticleId>
            <ArticleId IdType="pubmed">29864439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park K, Lee K, Zhang B, Zhou T, He X, Gao G, Murray AR, Ma JX. Identification of a novel inhibitor of the canonical Wnt pathway. Mol Cell Biol. 2011;31:3038–3051. doi: 10.1128/MCB.01211-10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.01211-10</ArticleId>
            <ArticleId IdType="pmc">PMC3133395</ArticleId>
            <ArticleId IdType="pubmed">21576363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dai Z, Lu L, Yang Z, Mao Y, Lu J, Li C, Qi W, Chen Y, Yao Y, Li L, et al.  Kallikrein-binding protein inhibits LPS-induced TNF-α by upregulating SOCS3 expression. J Cell Biochem. 2013;114:1020–1028. doi: 10.1002/jcb.24441.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcb.24441</ArticleId>
            <ArticleId IdType="pubmed">23129128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang J, Yang Z, Li P, Bledsoe G, Chao L, Chao J. Kallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6. Mol Cell Biochem. 2013;379:295–301. doi: 10.1007/s11010-013-1654-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11010-013-1654-2</ArticleId>
            <ArticleId IdType="pmc">PMC4108187</ArticleId>
            <ArticleId IdType="pubmed">23666756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu SL, Tsai C Y, Luo YH, Kuo C F, Lin WC, Chang YT, Wu JJ, Chuang WJ, Liu CC, Chao L, et al.  Kallistatin modulates immune cells and confers anti-inflammatory response to protect mice from Group A streptococcal infection. Antimicrob Agents Chemother. 2013;57:5366–5372. doi: 10.1128/AAC.00322-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00322-13</ArticleId>
            <ArticleId IdType="pmc">PMC3811288</ArticleId>
            <ArticleId IdType="pubmed">23959316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McBride JD, Jenkins AJ, Liu X, Zhang B, Lee K, Berry WL, Janknecht R, Griffin CT, Aston CE, Lyons TJ, et al.  Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signaling. J Invest Dermatol. 2014;134:1725–1734. doi: 10.1038/jid.2014.40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/jid.2014.40</ArticleId>
            <ArticleId IdType="pmc">PMC4065799</ArticleId>
            <ArticleId IdType="pubmed">24463424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bach RR. Initiation of coagulation by tissue factor. CRC Crit Rev Biochem. 1988;23:339–368. doi: 10.3109/10409238809082548.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/10409238809082548</ArticleId>
            <ArticleId IdType="pubmed">3067973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tuo J, Bojanowski CM, Zhou M, Shen D, Ross RJ, Rosenberg KI, Cameron DJ, Yin C, Kowalak JA, Zhuang Z, et al.  Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Invest Ophthalmol Vis Sci. 2007;48:3827–3836. doi: 10.1167/iovs.07-0051.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1167/iovs.07-0051</ArticleId>
            <ArticleId IdType="pmc">PMC2048751</ArticleId>
            <ArticleId IdType="pubmed">17652758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan CC, Ross RJ, Shen D, Ding X, Majumdar Z, Bojanowski CM, Zhou M, Salem N, Jr, Bonner R, Tuo J. Ccl2/Cx3cr1-deficient mice: An animal model for age-related macular degeneration. Ophthalmic Res. 2008;40:124–128. doi: 10.1159/000119862.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000119862</ArticleId>
            <ArticleId IdType="pmc">PMC2409067</ArticleId>
            <ArticleId IdType="pubmed">18421225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chu XK, Wang Y, Ardeljan D, Tuo J, Chan CC. Controversial view of a genetically altered mouse model of focal retinal degeneration. Bioengineered. 2013;4:130–135. doi: 10.4161/bioe.22949.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/bioe.22949</ArticleId>
            <ArticleId IdType="pmc">PMC3669152</ArticleId>
            <ArticleId IdType="pubmed">23196746</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tuo J, Ross RJ, Herzlich AA, Shen D, Ding X, Zhou M, Coon SL, Hussein N, Salem N, Jr, Chan CC. A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration. Am J Pathol. 2009;175:799–807. doi: 10.2353/ajpath.2009.090089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2353/ajpath.2009.090089</ArticleId>
            <ArticleId IdType="pmc">PMC2716974</ArticleId>
            <ArticleId IdType="pubmed">19608872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tuo J, Pang JJ, Cao X, Shen D, Zhang J, Scaria A, Wadsworth SC, Pechan P, Boye SL, Hauswirth WW, Chan CC. AAV5-mediated sFLT01 gene therapy arrests retinal lesions in Ccl2(-/-)/Cx3cr1(-/-) mice. Neurobiol Aging. 2012;33:433.e1–e10. doi: 10.1016/j.neurobiolaging.2011.01.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.01.009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang J, Tuo J, Cao X, Shen D, Li W, Chan CC. Early degeneration of photoreceptor synapse in Ccl2/Cx3cr1-deficient mice on Crb1(rd8) background. Synapse. 2013;67:515–531. doi: 10.1002/syn.21674.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/syn.21674</ArticleId>
            <ArticleId IdType="pmc">PMC3745602</ArticleId>
            <ArticleId IdType="pubmed">23592324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clemons TE, Milton RC, Klein R, Seddon JM. Risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS) AREDS report no. 19. Ophthalmology. 2005;112:533–539. doi: 10.1016/j.ophtha.2004.10.047.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ophtha.2004.10.047</ArticleId>
            <ArticleId IdType="pmc">PMC1513667</ArticleId>
            <ArticleId IdType="pubmed">15808240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Sang A, Zhu M, Zhang G, Guan H, Ji M, Chen H. Tissue factor induces VEGF expression via activation of the Wnt/β-catenin signaling pathway in ARPE-19 cells. Mol Vis. 2016;22:886–897.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4961466</ArticleId>
            <ArticleId IdType="pubmed">27499609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu F, Liu Z, Zhou Y, He J, Gong S, Bai X, Zeng Y, Liu Z, Ma JX. Decreased circulating levels of dickkopf-1 in patients with exudative age-related macular degeneration. Sci Rep. 2017;7:1263. doi: 10.1038/s41598-017-01119-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-017-01119-2</ArticleId>
            <ArticleId IdType="pmc">PMC5430640</ArticleId>
            <ArticleId IdType="pubmed">28455497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Voorzanger-Rousselot N, Goehrig D, Facon T, Clézardin P, Garnero P. Platelet is a major contributor to circulating levels of Dickkopf-1: Clinical implications in patients with multiple myeloma. Br J Haematol. 2009;145:264–266. doi: 10.1111/j.1365-2141.2009.07587.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2141.2009.07587.x</ArticleId>
            <ArticleId IdType="pubmed">19210508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Esen E, Chen J, Karner CM, Okunade AL, Patterson BW, Long F. WNT-LRP5 signaling induces Warburg effect through mTORC2 activation during osteoblast differentiation. Cell Metab. 2013;17:745–755. doi: 10.1016/j.cmet.2013.03.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2013.03.017</ArticleId>
            <ArticleId IdType="pmc">PMC3653292</ArticleId>
            <ArticleId IdType="pubmed">23623748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pate KT, Stringari C, Sprowl-Tanio S, Wang K, TeSlaa T, Hoverter NP, McQuade MM, Garner C, Digman MA, Teitell MA, et al.  Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. EMBO J. 2014;33:1454–1473. doi: 10.15252/embj.201488598.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15252/embj.201488598</ArticleId>
            <ArticleId IdType="pmc">PMC4194089</ArticleId>
            <ArticleId IdType="pubmed">24825347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thompson CB. Wnt meets Warburg: Another piece in the puzzle? EMBO J. 2014;33:1420–1422. doi: 10.15252/embj.201488785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15252/embj.201488785</ArticleId>
            <ArticleId IdType="pmc">PMC4194084</ArticleId>
            <ArticleId IdType="pubmed">24843042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lum JJ, Bui T, Gruber M, Gordan JD, DeBerardinis RJ, Covello KL, Simon MC, Thompson CB. The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev. 2007;21:1037–1049. doi: 10.1101/gad.1529107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.1529107</ArticleId>
            <ArticleId IdType="pmc">PMC1855230</ArticleId>
            <ArticleId IdType="pubmed">17437992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manea A. NADPH oxidase-derived reactive oxygen species: Involvement in vascular physiology and pathology. Cell Tissue Res. 2010;342:325–339. doi: 10.1007/s00441-010-1060-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00441-010-1060-y</ArticleId>
            <ArticleId IdType="pubmed">21052718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radomska-Leśniewska DM, Hevelke A, Skopiński P, Bałan B, Jóźwiak J, Rokicki D, Skopińska-Różewska E, Białoszewska A. Reactive oxygen species and synthetic antioxidants as angiogenesis modulators: Clinical implications. Pharmacol Rep. 2016;68:462–471. doi: 10.1016/j.pharep.2015.10.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pharep.2015.10.002</ArticleId>
            <ArticleId IdType="pubmed">26922554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal. 2014;20:1126–1167. doi: 10.1089/ars.2012.5149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2012.5149</ArticleId>
            <ArticleId IdType="pmc">PMC3929010</ArticleId>
            <ArticleId IdType="pubmed">23991888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim YW, West XZ, Byzova TV. Inflammation and oxidative stress in angiogenesis and vascular disease. J Mol Med (Berl) 2013;91:323–328. doi: 10.1007/s00109-013-1007-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00109-013-1007-3</ArticleId>
            <ArticleId IdType="pmc">PMC3656485</ArticleId>
            <ArticleId IdType="pubmed">23430240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brambilla D, Mancuso C, Scuderi MR, Bosco P, Cantarella G, Lempereur L, Di Benedetto G, Pezzino S, Bernardini R. The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: A point of view for an assessment of the risk/benefit profile. Nutr J. 2008;7:29. doi: 10.1186/1475-2891-7-29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1475-2891-7-29</ArticleId>
            <ArticleId IdType="pmc">PMC2572622</ArticleId>
            <ArticleId IdType="pubmed">18826565</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473:298–307. doi: 10.1038/nature10144.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature10144</ArticleId>
            <ArticleId IdType="pmc">PMC4049445</ArticleId>
            <ArticleId IdType="pubmed">21593862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim YW, Byzova TV. Oxidative stress in angiogenesis and vascular disease. Blood. 2014;123:625–631. doi: 10.1182/blood-2013-09-512749.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2013-09-512749</ArticleId>
            <ArticleId IdType="pmc">PMC3907751</ArticleId>
            <ArticleId IdType="pubmed">24300855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vallée A, Lecarpentier Y, Vallée R, Guillevin R, Vallée JN. Circadian rhythms in exudative age-related macular degeneration: The key role of the canonical WNT/β-catenin pathway. Int J Mol Sci. 2020;21:820. doi: 10.3390/ijms21030820.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms21030820</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brugarolas JB, Vazquez F, Reddy A, Sellers WR, Kaelin WG. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell. 2003;4:147–158. doi: 10.1016/S1535-6108(03)00187-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1535-6108(03)00187-9</ArticleId>
            <ArticleId IdType="pubmed">12957289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Düvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, Triantafellow E, Ma Q, Gorski R, Cleaver S, et al.  Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell. 2010;39:171–183. doi: 10.1016/j.molcel.2010.06.022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2010.06.022</ArticleId>
            <ArticleId IdType="pmc">PMC2946786</ArticleId>
            <ArticleId IdType="pubmed">20670887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jung JE, Lee HG, Cho IH, Chung DH, Yoon SH, Yang YM, Lee JW, Choi S, Park JW, Ye SK, Chung MH. STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J. 2005;19:1296–1298. doi: 10.1096/fj.04-3099fje.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1096/fj.04-3099fje</ArticleId>
            <ArticleId IdType="pubmed">15919761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Land SC, Tee AR. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem. 2007;282:20534–20543. doi: 10.1074/jbc.M611782200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M611782200</ArticleId>
            <ArticleId IdType="pubmed">17502379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toschi A, Lee E, Gadir N, Ohh M, Foster DA. Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2. J Biol Chem. 2008;283:34495–34499. doi: 10.1074/jbc.C800170200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.C800170200</ArticleId>
            <ArticleId IdType="pmc">PMC2596400</ArticleId>
            <ArticleId IdType="pubmed">18945681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Q, Briggs J, Park S, Niu G, Kortylewski M, Zhang S, Gritsko T, Turkson J, Kay H, Semenza GL, et al.  Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene. 2005;24:5552–5560. doi: 10.1038/sj.onc.1208719.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.onc.1208719</ArticleId>
            <ArticleId IdType="pubmed">16007214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim J, Gao P, Liu YC, Semenza GL, Dang CV. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol. 2007;27:7381–7393. doi: 10.1128/MCB.00440-07.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.00440-07</ArticleId>
            <ArticleId IdType="pmc">PMC2169056</ArticleId>
            <ArticleId IdType="pubmed">17785433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suda T, Takubo K, Semenza GL. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell. 2011;9:298–310. doi: 10.1016/j.stem.2011.09.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stem.2011.09.010</ArticleId>
            <ArticleId IdType="pubmed">21982230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Firth JD, Ebert BL, Ratcliffe PJ. Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements. J Biol Chem. 1995;270:21021–21027. doi: 10.1074/jbc.270.36.21021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.270.36.21021</ArticleId>
            <ArticleId IdType="pubmed">7673128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewis BC, Shim H, Li Q, Wu CS, Lee LA, Maity A, Dang CV. Identification of putative c-Myc-responsive genes: Characterization of rcl, a novel growth-related gene. Mol Cell Biol. 1997;17:4967–4978. doi: 10.1128/MCB.17.9.4967.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.17.9.4967</ArticleId>
            <ArticleId IdType="pmc">PMC232348</ArticleId>
            <ArticleId IdType="pubmed">9271375</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, Giallongo A. Hypoxia response elements in the Aldolase A, Enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem. 1996;271:32529–32537. doi: 10.1074/jbc.271.51.32529.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.271.51.32529</ArticleId>
            <ArticleId IdType="pubmed">8955077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shim H, Dolde C, Lewis BC, Wu CS, Dang G, Jungmann RA, Dalla-Favera R, Dang CV. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci USA. 1997;94:6658–6663. doi: 10.1073/pnas.94.13.6658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.94.13.6658</ArticleId>
            <ArticleId IdType="pmc">PMC21214</ArticleId>
            <ArticleId IdType="pubmed">9192621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warburg O. On the origin of cancer cells. Science. 1956;123:309–314. doi: 10.1126/science.123.3191.309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.123.3191.309</ArticleId>
            <ArticleId IdType="pubmed">13298683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koukourakis MI, Giatromanolaki A, Sivridis E, Bougioukas G, Didilis V, Gatter KC, Harris AL, Tumour and Angiogenesis Research Group  Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer. 2003;89:877–885. doi: 10.1038/sj.bjc.6601205.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.bjc.6601205</ArticleId>
            <ArticleId IdType="pmc">PMC2394471</ArticleId>
            <ArticleId IdType="pubmed">12942121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vallée A, Lecarpentier Y, Guillevin R, Vallée JN. Aerobic glycolysis hypothesis through WNT/beta-catenin pathway in exudative age-related macular degeneration. J Mol Neurosci. 2017;62:368–379. doi: 10.1007/s12031-017-0947-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12031-017-0947-4</ArticleId>
            <ArticleId IdType="pubmed">28689265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Léveillard T, Sahel JA. Metabolic and redox signaling in the retina. Cell Mol Life Sci. 2017;74:3649–3665. doi: 10.1007/s00018-016-2318-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-016-2318-7</ArticleId>
            <ArticleId IdType="pmc">PMC5597695</ArticleId>
            <ArticleId IdType="pubmed">27543457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oguma K, Oshima H, Oshima M. Inflammation, tumor necrosis factor and Wnt promotion in gastric cancer development. Future Oncol. 2010;6:515–526. doi: 10.2217/fon.10.13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2217/fon.10.13</ArticleId>
            <ArticleId IdType="pubmed">20373866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schön S, Flierman I, Ofner A, Stahringer A, Holdt LM, Kolligs FT, Herbst A. β-catenin regulates NF-κB activity via TNFRSF19 in colorectal cancer cells. Int J Cancer. 2014;135:1800–1811. doi: 10.1002/ijc.28839.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.28839</ArticleId>
            <ArticleId IdType="pubmed">24623448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oh H, Takagi H, Takagi C, Suzuma K, Otani A, Ishida K, Matsumura M, Ogura Y, Honda Y. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1999;40:1891–1898.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10440240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cousins SW, Espinosa-Heidmann DG, Csaky KG. Monocyte activation in patients with age-related macular degeneration: A biomarker of risk for choroidal neovascularization? Arch Ophthalmol. 2004;122:1013–1018. doi: 10.1001/archopht.122.7.1013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archopht.122.7.1013</ArticleId>
            <ArticleId IdType="pubmed">15249366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duguid IG, Boyd AW, Mandel TE. Adhesion molecules are expressed in the human retina and choroid. Curr Eye Res. 1992;11(Suppl):S153–S159. doi: 10.3109/02713689208999526.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/02713689208999526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elner SG, Elner VM, Pavilack MA, Todd RF, III, Mayo-Bond L, Franklin WA, Strieter RM, Kunkel SL, Huber AR. Modulation and function of intercellular adhesion molecule-1 (CD54) on human retinal pigment epithelial cells. Lab Invest. 1992;66:200–211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1346541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134:411–431. doi: 10.1016/S0002-9394(02)01624-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0002-9394(02)01624-0</ArticleId>
            <ArticleId IdType="pubmed">12208254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2006;51:137–152. doi: 10.1016/j.survophthal.2005.12.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.survophthal.2005.12.001</ArticleId>
            <ArticleId IdType="pmc">PMC4853913</ArticleId>
            <ArticleId IdType="pubmed">16500214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garrett E, Wiesmann M, Garcia PD, Fuller JH, Chan V, et al.  Beta-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res. 2003;63:3145–3153.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12810642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ip MS, Scott IU, Brown GC, Brown MM, Ho AC, Huang SS, Recchia FM, American Academy of Ophthalmology  Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: A report by the American Academy of Ophthalmology. Ophthalmology. 2008;115:1837–1846. doi: 10.1016/j.ophtha.2008.08.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ophtha.2008.08.012</ArticleId>
            <ArticleId IdType="pubmed">18929163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolf S. Current status of anti-vascular endothelial growth factor therapy in Europe. Jpn J Ophthalmol. 2008;52:433–439. doi: 10.1007/s10384-008-0580-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10384-008-0580-4</ArticleId>
            <ArticleId IdType="pubmed">19089562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menon G, Walters G. New paradigms in the treatment of wet AMD: The impact of anti-VEGF therapy. Eye (Lond) 2009;23(Suppl 1):S1–S7. doi: 10.1038/eye.2009.13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/eye.2009.13</ArticleId>
            <ArticleId IdType="pubmed">19287467</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grisanti S, Zhu Q, Tatar O, Lueke J, Lueke M, Tura A, Grisanti S. Differential expression of vascular endothelial growth factor-a isoforms in neovascular age-related macular degeneration. Retina. 2015;35:764–772. doi: 10.1097/IAE.0000000000000385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/IAE.0000000000000385</ArticleId>
            <ArticleId IdType="pubmed">25494018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X. Overstimulation can create health problems due to increases in PI3K/Akt/GSK3 insensitivity and GSK3 activity. Springerplus. 2014;3:356. doi: 10.1186/2193-1801-3-356.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/2193-1801-3-356</ArticleId>
            <ArticleId IdType="pmc">PMC4117863</ArticleId>
            <ArticleId IdType="pubmed">25089247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang P, Wang Y, Hui Y, Hu D, Wang H, Zhou J, Du H. Inhibition of VEGF expression by targeting HIF-1 alpha with small interference RNA in human RPE cells. Ophthalmologica. 2007;221:411–417. doi: 10.1159/000107502.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000107502</ArticleId>
            <ArticleId IdType="pubmed">17947829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang P, Zhang X, Hao X, Wang Y, Hui Y, Wang H, Hu D, Zhou J. Rac1 activates HIF-1 in retinal pigment epithelium cells under hypoxia. Graefes Arch Clin Exp Ophthalmol. 2009;247:633–639. doi: 10.1007/s00417-008-1031-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00417-008-1031-0</ArticleId>
            <ArticleId IdType="pubmed">19165496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arjamaa O, Nikinmaa M, Salminen A, Kaarniranta K. Regulatory role of HIF-1alpha in the pathogenesis of age-related macular degeneration (AMD) Ageing Res Rev. 2009;8:349–358. doi: 10.1016/j.arr.2009.06.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.arr.2009.06.002</ArticleId>
            <ArticleId IdType="pubmed">19589398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Trarbach T, Folprecht G, Shi MM, Lebwohl D, Jalava T, Laurent D, et al.  Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy. Clin Cancer Res. 2011;17:4892–4900. doi: 10.1158/1078-0432.CCR-10-2918.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1078-0432.CCR-10-2918</ArticleId>
            <ArticleId IdType="pmc">PMC3145151</ArticleId>
            <ArticleId IdType="pubmed">21632858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giatromanolaki A, Sivridis E, Gatter KC, Turley H, Harris AL, Koukourakis MI, Tumour and Angiogenesis Research Group  Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis. Gynecol Oncol. 2006;103:912–918. doi: 10.1016/j.ygyno.2006.05.043.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ygyno.2006.05.043</ArticleId>
            <ArticleId IdType="pubmed">16837029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kolev Y, Uetake H, Takagi Y, Sugihara K. Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: Association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis. Ann Surg Oncol. 2008;15:2336–2344. doi: 10.1245/s10434-008-9955-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1245/s10434-008-9955-5</ArticleId>
            <ArticleId IdType="pubmed">18521687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dhup S, Dadhich RK, Porporato PE, Sonveaux P. Multiple biological activities of lactic acid in cancer: Influences on tumor growth, angiogenesis and metastasis. Curr Pharm Des. 2012;18:1319–1330. doi: 10.2174/138161212799504902.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/138161212799504902</ArticleId>
            <ArticleId IdType="pubmed">22360558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Polet F, Feron O. Endothelial cell metabolism and tumour angiogenesis: Glucose and glutamine as essential fuels and lactate as the driving force. J Intern Med. 2013;273:156–165. doi: 10.1111/joim.12016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/joim.12016</ArticleId>
            <ArticleId IdType="pubmed">23216817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>San-Millán I, Brooks GA. Reexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect. Carcinogenesis. 2017;38:119–133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5862360</ArticleId>
            <ArticleId IdType="pubmed">27993896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu W, Zhai Y, Heng X, Che FY, Chen W, Sun D, Zhai G. Oral bioavailability of curcumin: problems and advancements. J Drug Target. 2016;24:694–702. doi: 10.3109/1061186X.2016.1157883.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/1061186X.2016.1157883</ArticleId>
            <ArticleId IdType="pubmed">26942997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vallée A, Lecarpentier Y. Curcumin and endometriosis. Int J Mol Sci. 2020;21:2440. doi: 10.3390/ijms21072440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms21072440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kotha RR, Luthria DL. Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects. Molecules. 2019;24:2930. doi: 10.3390/molecules24162930.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules24162930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prasad S, Gupta SC, Tyagi AK, Aggarwal BB. Curcumin, a component of golden spice: From bedside to bench and back. Biotechnol Adv. 2014;32:1053–1064. doi: 10.1016/j.biotechadv.2014.04.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biotechadv.2014.04.004</ArticleId>
            <ArticleId IdType="pubmed">24793420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Priyadarsini KI. The chemistry of curcumin: From extraction to therapeutic agent. Molecules. 2014;19:20091–20112. doi: 10.3390/molecules191220091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules191220091</ArticleId>
            <ArticleId IdType="pmc">PMC6270789</ArticleId>
            <ArticleId IdType="pubmed">25470276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Zhu W, Yang C, Guo H, Yu A, Ji J, Gao Y, Sun M, Zhai G. A novel folate-modified self-microemulsifying drug delivery system of curcumin for colon targeting. Int J Nanomedicine. 2012;7:151–162.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3263408</ArticleId>
            <ArticleId IdType="pubmed">22275831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shen L, Liu CC, An CY, Ji HF. How does curcumin work with poor bioavailability? Clues from experimental and theoretical studies. Sci Rep. 2016;6:20872. doi: 10.1038/srep20872.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep20872</ArticleId>
            <ArticleId IdType="pmc">PMC4757858</ArticleId>
            <ArticleId IdType="pubmed">26887346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun M, Su X, Ding B, He X, Liu X, Yu A, Lou H, Zhai G. Advances in nanotechnology-based delivery systems for curcumin. Nanomedicine (Lond) 2012;7:1085–1100. doi: 10.2217/nnm.12.80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2217/nnm.12.80</ArticleId>
            <ArticleId IdType="pubmed">22846093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naksuriya O, Okonogi S, Schiffelers RM, Hennink WE. Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials. 2014;35:3365–3383. doi: 10.1016/j.biomaterials.2013.12.090.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biomaterials.2013.12.090</ArticleId>
            <ArticleId IdType="pubmed">24439402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malam Y, Loizidou M, Seifalian AM. Liposomes and nanoparticles: Nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci. 2009;30:592–599. doi: 10.1016/j.tips.2009.08.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tips.2009.08.004</ArticleId>
            <ArticleId IdType="pubmed">19837467</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee WH, Loo CY, Young PM, Traini D, Mason RS, Rohanizadeh R. Recent advances in curcumin nanoformulation for cancer therapy. Expert Opin Drug Deliv. 2014;11:1183–1201. doi: 10.1517/17425247.2014.916686.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/17425247.2014.916686</ArticleId>
            <ArticleId IdType="pubmed">24857605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hatefi A, Amsden B. Biodegradable injectable in situ forming drug delivery systems. J Control Release. 2002;80:9–28. doi: 10.1016/S0168-3659(02)00008-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0168-3659(02)00008-1</ArticleId>
            <ArticleId IdType="pubmed">11943384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yallapu MM, Jaggi M, Chauhan SC. Beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B Biointerfaces. 2010;79:113–125. doi: 10.1016/j.colsurfb.2010.03.039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.colsurfb.2010.03.039</ArticleId>
            <ArticleId IdType="pubmed">20456930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radomska-Leśniewska DM, Osiecka-Iwan A, Hyc A, Góźdź A, Dąbrowska AM, Skopiński P. Therapeutic potential of curcumin in eye diseases. Cent Eur J Immunol. 2019;44:181–189. doi: 10.5114/ceji.2019.87070.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5114/ceji.2019.87070</ArticleId>
            <ArticleId IdType="pmc">PMC6745545</ArticleId>
            <ArticleId IdType="pubmed">31530988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu W, Wu Y, Meng YF, Wang JY, Xu M, Tao JJ, Lu J. Effect of curcumin on aging retinal pigment epithelial cells. Drug Des Devel Ther. 2015;9:5337–5344.</Citation>
        </Reference>
        <Reference>
          <Citation>Jiang X, Li S, Qiu X, Cong J, Zhou J, Miu W. Curcumin inhibits cell viability and increases apoptosis of SW620 human colon adenocarcinoma cells via the caudal type homeobox-2 (CDX2)/Wnt/β-catenin pathway. Med Sci Monit. 2019;25:7451–7458. doi: 10.12659/MSM.918364.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12659/MSM.918364</ArticleId>
            <ArticleId IdType="pmc">PMC6792517</ArticleId>
            <ArticleId IdType="pubmed">31584928</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Howell JC, Chun E, Farrell AN, Hur EY, Caroti CM, Iuvone PM, Haque R. Global microRNA expression profiling: Curcumin (diferuloylmethane) alters oxidative stress-responsive microRNAs in human ARPE-19 cells. Mol Vis. 2013;19:544–560.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3611939</ArticleId>
            <ArticleId IdType="pubmed">23559849</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mandal MNA, Patlolla JMR, Zheng L, Agbaga MP, Tran JT, Wicker L, Kasus-Jacobi A, Elliott MH, Rao CV, Anderson RE. Curcumin protects retinal cells from light-and oxidant stress-induced cell death. Free Radic Biol Med. 2009;46:672–679. doi: 10.1016/j.freeradbiomed.2008.12.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2008.12.006</ArticleId>
            <ArticleId IdType="pmc">PMC2810836</ArticleId>
            <ArticleId IdType="pubmed">19121385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muangnoi C, Sharif U, Ratnatilaka Na, Bhuket P, Rojsitthisak P, Paraoan L. Protective effects of curcumin ester prodrug, curcumin diethyl disuccinate against H2O2-Induced oxidative stress in human retinal pigment epithelial cells: Potential therapeutic avenues for age-related macular degeneration. Int J Mol Sci. 2019;20:3367. doi: 10.3390/ijms20133367.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms20133367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim HJ, Park SY, Park OJ, Kim YM. Curcumin suppresses migration and proliferation of Hep3B hepatocarcinoma cells through inhibition of the Wnt signaling pathway. Mol Med Rep. 2013;8:282–286. doi: 10.3892/mmr.2013.1497.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/mmr.2013.1497</ArticleId>
            <ArticleId IdType="pubmed">23723038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leow PC, Bahety P, Boon CP, Lee CY, Tan KL, Yang T, Ee PL. Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway. Eur J Med Chem. 2014;71:67–80. doi: 10.1016/j.ejmech.2013.10.073.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejmech.2013.10.073</ArticleId>
            <ArticleId IdType="pubmed">24275249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kolb TM, Davis MA. The tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) provokes a prolonged morphologic response and ERK activation in Tsc2-null renal tumor cells. Toxicol Sci. 2004;81:233–242. doi: 10.1093/toxsci/kfh183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/toxsci/kfh183</ArticleId>
            <ArticleId IdType="pubmed">15178807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, Ranga U, Kundu TK. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem. 2004;279:51163–51171. doi: 10.1074/jbc.M409024200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M409024200</ArticleId>
            <ArticleId IdType="pubmed">15383533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He M, Li Y, Zhang L, Li L, Shen Y, Lin L, Zheng W, Chen L, Bian X, Ng HK, Tang L. Curcumin suppresses cell proliferation through inhibition of the Wnt/β-catenin signaling pathway in medulloblastoma. Oncol Rep. 2014;32:173–180. doi: 10.3892/or.2014.3206.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/or.2014.3206</ArticleId>
            <ArticleId IdType="pubmed">24858998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol. 2007;595:105–125. doi: 10.1007/978-0-387-46401-5_3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-0-387-46401-5_3</ArticleId>
            <ArticleId IdType="pubmed">17569207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marchiani A, Rozzo C, Fadda A, Delogu G, Ruzza P. Curcumin and curcumin-like molecules: From spice to drugs. Curr Med Chem. 2014;21:204–222. doi: 10.2174/092986732102131206115810.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/092986732102131206115810</ArticleId>
            <ArticleId IdType="pubmed">23590716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schneider C, Boeglin WE, Yin H, Stec DF, Voehler M. Convergent oxygenation of arachidonic acid by 5-lipoxygenase and cyclooxygenase-2. J Am Chem Soc. 2006;128:720–721. doi: 10.1021/ja056517y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/ja056517y</ArticleId>
            <ArticleId IdType="pmc">PMC2532595</ArticleId>
            <ArticleId IdType="pubmed">16417352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giménez-Bastida JA, González-Sarrías A, Laparra-Llopis JM, Schneider C, Espín JC. Targeting mammalian 5-lipoxygenase by dietary phenolics as an anti-inflammatory mechanism: A systematic review. Int J Mol Sci. 2021;22:7937. doi: 10.3390/ijms22157937.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms22157937</ArticleId>
            <ArticleId IdType="pmc">PMC8348464</ArticleId>
            <ArticleId IdType="pubmed">34360703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Othman A, Ahmad S, Megyerdi S, Mussell R, Choksi K, Maddipati KR, Elmarakby A, Rizk N, Al-Shabrawey M. 12/15-Lipoxygenase-derived lipid metabolites induce retinal endothelial cell barrier dysfunction: Contribution of NADPH oxidase. PLoS One. 2013;8:e57254. doi: 10.1371/journal.pone.0057254.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0057254</ArticleId>
            <ArticleId IdType="pmc">PMC3577708</ArticleId>
            <ArticleId IdType="pubmed">23437353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Subramanian P, Mendez EF, Becerra SP. A novel inhibitor of 5-Lipoxygenase (5-LOX) prevents oxidative stress-induced cell death of retinal pigment epithelium (RPE) cells. Invest Ophthalmol Vis Sci. 2016;57:4581–4588. doi: 10.1167/iovs.15-19039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1167/iovs.15-19039</ArticleId>
            <ArticleId IdType="pmc">PMC5033602</ArticleId>
            <ArticleId IdType="pubmed">27635633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yadav UCS, Ramana KV. Regulation of NF-κB-induced inflammatory signaling by lipid peroxidation-derived aldehydes. Oxid Med Cell Longev. 2013;2013:690545. doi: 10.1155/2013/690545.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2013/690545</ArticleId>
            <ArticleId IdType="pmc">PMC3654319</ArticleId>
            <ArticleId IdType="pubmed">23710287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruan Y, Jiang S, Gericke A. Age-related macular degeneration: Role of oxidative stress and blood vessels. Int J Mol Sci. 2021;22:1296. doi: 10.3390/ijms22031296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms22031296</ArticleId>
            <ArticleId IdType="pmc">PMC7866075</ArticleId>
            <ArticleId IdType="pubmed">33525498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yabas M, Orhan C, Er B, Tuzcu M, Durmus AS, Ozercan IH, Sahin N, Bhanuse P, Morde AA, Padigaru M, Sahin K. A next generation formulation of curcumin ameliorates experimentally induced osteoarthritis in rats via regulation of inflammatory mediators. Front Immunol. 2021;12:609629. doi: 10.3389/fimmu.2021.609629.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2021.609629</ArticleId>
            <ArticleId IdType="pmc">PMC7994281</ArticleId>
            <ArticleId IdType="pubmed">33776996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X, Lu Y, Jin Y, Son JK, Lee SH, Chang HW. Curcumin inhibits the activation of immunoglobulin e-mediated mast cells and passive systemic anaphylaxis in mice by reducing serum eicosanoid and histamine levels. Biomol Ther (Seoul) 2014;22:27–34. doi: 10.4062/biomolther.2013.092.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4062/biomolther.2013.092</ArticleId>
            <ArticleId IdType="pmc">PMC3936421</ArticleId>
            <ArticleId IdType="pubmed">24596618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manjunatha H, Srinivasan K. Protective effect of dietary curcumin and capsaicin on induced oxidation of low-density lipoprotein, iron-induced hepatotoxicity and carrageenan-induced inflammation in experimental rats. FEBS J. 2006;273:4528–4537. doi: 10.1111/j.1742-4658.2006.05458.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1742-4658.2006.05458.x</ArticleId>
            <ArticleId IdType="pubmed">16956363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Priyadarsini KI, Maity DK, Naik GH, Kumar MS, Unnikrishnan MK, Satav JG, Mohan H. Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin. Free Radic Biol Med. 2003;35:475–484. doi: 10.1016/S0891-5849(03)00325-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0891-5849(03)00325-3</ArticleId>
            <ArticleId IdType="pubmed">12927597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piwocka K, Jaruga E, Skierski J, Gradzka I, Sikora E. Effect of glutathione depletion on caspase-3 independent apoptosis pathway induced by curcumin in Jurkat cells. Free Radic Biol Med. 2001;31:670–678. doi: 10.1016/S0891-5849(01)00629-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0891-5849(01)00629-3</ArticleId>
            <ArticleId IdType="pubmed">11522452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Motterlini R, Foresti R, Bassi R, Green CJ. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med. 2000;28:1303–1312. doi: 10.1016/S0891-5849(00)00294-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0891-5849(00)00294-X</ArticleId>
            <ArticleId IdType="pubmed">10889462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao K, Dong YT, Xiang J, Xu Y, Hong W, Song H, Guan ZZ. Reduced expression of SIRT1 and SOD-1 and the correlation between these levels in various regions of the brains of patients with Alzheimer's disease. J Clin Pathol. 2018;71:1090–1099. doi: 10.1136/jclinpath-2018-205320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jclinpath-2018-205320</ArticleId>
            <ArticleId IdType="pubmed">30185534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Golestaneh N, Chu Y, Cheng SK, Cao H, Poliakov E, Berinstein DM. Repressed SIRT1/PGC-1α pathway and mitochondrial disintegration in iPSC-derived RPE disease model of age-related macular degeneration. J Transl Med. 2016;14:344. doi: 10.1186/s12967-016-1101-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12967-016-1101-8</ArticleId>
            <ArticleId IdType="pmc">PMC5175395</ArticleId>
            <ArticleId IdType="pubmed">27998274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zuo L, Khan RS, Lee V, Dine K, Wu W, Shindler KS. SIRT1 promotes RGC survival and delays loss of function following optic nerve crush. Invest Ophthalmol Vis Sci. 2013;54:5097–5102. doi: 10.1167/iovs.13-12157.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1167/iovs.13-12157</ArticleId>
            <ArticleId IdType="pmc">PMC3726244</ArticleId>
            <ArticleId IdType="pubmed">23821198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li K, Zhai M, Jiang L, Song F, Zhang B, Li J, Li H, Li B, Xia L, Xu L, et al.  Tetrahydrocurcumin ameliorates diabetic cardiomyopathy by attenuating high glucose-induced oxidative stress and fibrosis via activating the SIRT1 Pathway. Oxid Med Cell Longev. 2019;2019:6746907. doi: 10.1155/2019/6746907.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2019/6746907</ArticleId>
            <ArticleId IdType="pmc">PMC6532281</ArticleId>
            <ArticleId IdType="pubmed">31210844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghasemi F, Shafiee M, Banikazemi Z, Pourhanifeh MH, Khanbabaei H, Shamshirian A, Amiri Moghadam S, ArefNezhad R, Sahebkar A, Avan A, Mirzaei H. Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells. Pathol Res Pract. 2019;215:152556. doi: 10.1016/j.prp.2019.152556.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.prp.2019.152556</ArticleId>
            <ArticleId IdType="pubmed">31358480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olivera A, Moore TW, Hu F, Brown AP, Sun A, Liotta DC, Snyder JP, Yoon Y, Shim H, Marcus AI, et al.  Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): Anti-inf lammatory and anti-cancer properties. Int Immunopharmacol. 2012;12:368–377. doi: 10.1016/j.intimp.2011.12.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.intimp.2011.12.009</ArticleId>
            <ArticleId IdType="pmc">PMC3372981</ArticleId>
            <ArticleId IdType="pubmed">22197802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>da Cruz BO, Cardozo LFM de F, Magliano DC, Stockler-Pinto MB. Nutritional strategies to modulate inflammation pathways via regulation of peroxisome proliferator-activated receptor β/δ. Nutr Rev. 2020;78:207–214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31584650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin YG, Kunnumakkara AB, Nair A, Merritt WM, Han LY, Armaiz-Pena GN, Kamat AA, Spannuth WA, Gershenson DM, Lutgendorf SK, et al.  Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Cancer Res. 2007;13:3423–3430. doi: 10.1158/1078-0432.CCR-06-3072.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1078-0432.CCR-06-3072</ArticleId>
            <ArticleId IdType="pubmed">17545551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang ZB, Luo DD, Xie JH, Xian YF, Lai ZQ, Liu YH, Liu WH, Chen JN, Lai XP, Lin ZX, Su ZR. Curcumin's metabolites, tetrahydrocurcumin and octahydrocurcumin, possess superior anti-inflammatory effects in vivo through suppression of TAK1-NF-κB pathway. Front Pharmacol. 2018;9:1181. doi: 10.3389/fphar.2018.01181.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2018.01181</ArticleId>
            <ArticleId IdType="pmc">PMC6199526</ArticleId>
            <ArticleId IdType="pubmed">30386242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen W, Chen Y, Cui G. Effects of TNF-alpha and curcumin on the expression of VEGF in Raji and U937 cells and on angiogenesis in ECV304 cells. Chin Med J (Engl) 2005;118:2052–2057.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16438902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoysungnoen P, Wirachwong P, Bhattarakosol P, Niimi H, Patumraj S. Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice. Clin Hemorheol Microcirc. 2006;34:109–115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16543625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li L, Braiteh FS, Kurzrock R. Liposome-encapsulated curcumin: In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer. 2005;104:1322–1331. doi: 10.1002/cncr.21300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cncr.21300</ArticleId>
            <ArticleId IdType="pubmed">16092118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arbiser JL, Klauber N, Rohan R, van Leeuwen R, Huang MT, Fisher C, Flynn E, Byers HR. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med. 1998;4:376–383. doi: 10.1007/BF03401744.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF03401744</ArticleId>
            <ArticleId IdType="pmc">PMC2230271</ArticleId>
            <ArticleId IdType="pubmed">10780880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gururaj AE, Belakavadi M, Venkatesh DA, Marmé D, Salimath BP. Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun. 2002;297:934–942. doi: 10.1016/S0006-291X(02)02306-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0006-291X(02)02306-9</ArticleId>
            <ArticleId IdType="pubmed">12359244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zahra FT, Sajib MS, Mikelis CM. Role of bFGF in acquired resistance upon Anti-VEGF therapy in cancer. Cancers (Basel) 2021;13:1422. doi: 10.3390/cancers13061422.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cancers13061422</ArticleId>
            <ArticleId IdType="pmc">PMC8003808</ArticleId>
            <ArticleId IdType="pubmed">33804681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Compagni A, Wilgenbus P, Impagnatiello MA, Cotten M, Christofori G. Fibroblast growth factors are required for efficient tumor angiogenesis. Cancer Res. 2000;60:7163–7169.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11156426</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nissen LJ, Cao R, Hedlund EM, Wang Z, Zhao X, Wetterskog D, Funa K, Bråkenhielm E, Cao Y. Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. J Clin Invest. 2007;117:2766–2777. doi: 10.1172/JCI32479.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI32479</ArticleId>
            <ArticleId IdType="pmc">PMC1994630</ArticleId>
            <ArticleId IdType="pubmed">17909625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Casanovas O, Hicklin DJ, Bergers G, Hanahan D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell. 2005;8:299–309. doi: 10.1016/j.ccr.2005.09.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2005.09.005</ArticleId>
            <ArticleId IdType="pubmed">16226705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi HJ, Armaiz Pena GN, Pradeep S, Cho MS, Coleman RL, Sood AK. Anti-vascular therapies in ovarian cancer: Moving beyond anti-VEGF approaches. Cancer Metastasis Rev. 2015;34:19–40. doi: 10.1007/s10555-014-9538-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10555-014-9538-9</ArticleId>
            <ArticleId IdType="pmc">PMC4369424</ArticleId>
            <ArticleId IdType="pubmed">25544368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aggarwal BB, Natarajan K. Tumor necrosis factors: Developments during the last decade. Eur Cytokine Netw. 1996;7:93–124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8688493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li H, Soria C, Griscelli F, Opolon P, Soria J, Yeh P, Legrand C, Vannier JP, Belin D, Perricaudet M, Lu H. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: Respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway. Hum Gene Ther. 2005;16:1157–1167. doi: 10.1089/hum.2005.16.1157.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/hum.2005.16.1157</ArticleId>
            <ArticleId IdType="pubmed">16218777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res. 2003;23:363–398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12680238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang LL, Sun Y, Huang K, Zheng L. Curcumin, a potential therapeutic candidate for retinal diseases. Mol Nutr Food Res. 2013;57:1557–1568. doi: 10.1002/mnfr.201200718.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mnfr.201200718</ArticleId>
            <ArticleId IdType="pubmed">23417969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pittalà V, Fidilio A, Lazzara F, Platania CBM, Salerno L, Foresti R, Drago F, Bucolo C. Effects of novel nitric oxide-releasing molecules against oxidative stress on retinal pigmented epithelial cells. Oxid Med Cell Longev. 2017;2017:1420892. doi: 10.1155/2017/1420892.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2017/1420892</ArticleId>
            <ArticleId IdType="pmc">PMC5660806</ArticleId>
            <ArticleId IdType="pubmed">29158871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bucolo C, Drago F, Maisto R, Romano GL, D'Agata V, Maugeri G, Giunta S. Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1/2-mediated activation of the Nrf2/HO-1 pathway. J Cell Physiol. 2019;234:17295–17304. doi: 10.1002/jcp.28347.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.28347</ArticleId>
            <ArticleId IdType="pubmed">30770549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vyas A, Dandawate P, Padhye S, Ahmad A, Sarkar F. Perspectives on New Synthetic curcumin analogs and their potential anticancer properties. Curr Pharm Des. 2013;19:2047–2069.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3788358</ArticleId>
            <ArticleId IdType="pubmed">23116312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muangnoi C, Ratnatilaka Na Bhuket P, Jithavech P, Supasena W, Paraoan L, Patumraj S, Rojsitthisak P. Curcumin diethyl disuccinate, a prodrug of curcumin, enhances anti-proliferative effect of curcumin against HepG2 cells via apoptosis induction. Sci Rep. 2019;9:11718. doi: 10.1038/s41598-019-48124-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-019-48124-1</ArticleId>
            <ArticleId IdType="pmc">PMC6690956</ArticleId>
            <ArticleId IdType="pubmed">31406217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohori H, Yamakoshi H, Tomizawa M, Shibuya M, Kakudo Y, Takahashi A, Takahashi S, Kato S, Suzuki T, Ishioka C, et al.  Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer. Mol Cancer Ther. 2006;5:2563–2571. doi: 10.1158/1535-7163.MCT-06-0174.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1535-7163.MCT-06-0174</ArticleId>
            <ArticleId IdType="pubmed">17041101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64:353–356. doi: 10.1055/s-2006-957450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-2006-957450</ArticleId>
            <ArticleId IdType="pubmed">9619120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sai N, Dong X, Huang P, You L, Yang C, Liu Y, Wang W, Wu H, Yu Y, Du Y, et al.  A novel gel-forming solution based on PEG-DSPE/Solutol HS 15 Mixed Micelles and Gellan Gum for ophthalmic delivery of curcumin. Molecules. 2019;25:81. doi: 10.3390/molecules25010081.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules25010081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang J, Sun H, Zhou N, Zhang B, Ma J. Preparation and evaluation of biodegradable scleral plug containing curcumin in rabbit eye. Curr Eye Res. 2017;42:1597–1603. doi: 10.1080/02713683.2016.1242753.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/02713683.2016.1242753</ArticleId>
            <ArticleId IdType="pubmed">29111828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mazzolani F, Togni S, Giacomelli L, Eggenhoffner R, Franceschi F. Oral administration of a curcumin-phospholipid formulation (Meriva®) for treatment of chronic diabetic macular edema: A pilot study. Eur Rev Med Pharmacol Sci. 2018;22:3617–3625.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29917217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allegri P, Mastromarino A, Neri P. Management of chronic anterior uveitis relapses: Efficacy of oral phospholipidic curcumin treatment. Long-term follow-up. Clin Ophthalmol. 2010;4:1201–1206.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2964958</ArticleId>
            <ArticleId IdType="pubmed">21060672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J, Smith LEH. Retinopathy of prematurity. Angiogenesis. 2007;10:133–140. doi: 10.1007/s10456-007-9066-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10456-007-9066-0</ArticleId>
            <ArticleId IdType="pubmed">17332988</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
